Merus N.V. EV/EBITDA Ratio 2011-2026 | MRUS

Annual EV/EBITDA Ratio Merus N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-10.4 K	-8.63	-3.68	-2.51	-3.51	-9.28	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.51	-10.4 K	-1.75 K

EV/EBITDA Ratio of other stocks in the Biotechnology industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-14.9	$ 9.13	-0.76 %	$ 591 M	USA
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	595	-	-	$ 866 M	China
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	29.4	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	-1.27	$ 15.52	-2.39 %	$ 49.6 M	USA
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	4.22 K	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	-21.1	$ 22.47	1.19 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	-1.19	-	-	$ 10.1 M	USA
Fortress Biotech FBIO	-0.152	$ 2.24	0.9 %	$ 62.5 M	USA
Galectin Therapeutics GALT	-1.92	$ 2.26	0.22 %	$ 144 M	USA
Galapagos NV GLPG	-26.5	$ 28.07	0.75 %	$ 2.69 B	Belgium
Advaxis ADXS	-82.4	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	13.7	$ 8.2	3.6 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	23	$ 31.01	-0.13 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
ImmuCell Corporation ICCC	23.1	$ 8.44	-	$ 76.2 M	USA
InflaRx N.V. IFRX	-3.65	$ 1.95	-1.77 %	$ 152 M	Germany
Immuron Limited IMRN	-106	$ 0.83	3.44 %	$ 6.55 M	Australia
Incyte Corporation INCY	24	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	14.6	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	-3.64	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	3.07	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	-5.59	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	4.1	$ 104.54	2.92 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.546	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-45.5	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	-0.625	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	-3.44	$ 26.67	-0.02 %	$ 1.44 B	Britain
Akero Therapeutics AKRO	-4.64	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	-6.65	$ 1.43	-4.03 %	$ 235 M	France
Kamada Ltd. KMDA	-386	$ 8.15	0.49 %	$ 260 M	Israel
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA
Allakos ALLK	-1.56	-	-	$ 28.6 M	USA
Kazia Therapeutics Limited KZIA	-1.24	$ 13.24	6.56 %	$ 1.75 B	Australia
AlloVir ALVR	-3.61	-	4.14 %	$ 49.1 M	USA
Ligand Pharmaceuticals Incorporated LGND	19.4	$ 223.98	-0.39 %	$ 4.1 B	USA
Can-Fite BioPharma Ltd. CANF	-43.1	$ 3.22	7.69 %	$ 5.3 M	Israel
Liquidia Corporation LQDA	-6.02	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	-20.4	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	-7.74	-	-	$ 867 M	Germany
Applied Therapeutics APLT	-0.476	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	388	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	-7.26	$ 4.08	0.74 %	$ 436 M	USA